Business

Second Sight Medical Products Announces Results of its 2021 Annual Meeting

LOS ANGELES--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable

articleVivani Medical, Inc.June 1, 20214/company/vivani-medical-inc/news/second-sight-medical-products-announces-results-of-its-2021-annual-meeting
Second Sight Medical Products Announces Results of its 2021 Annual Meeting

About this update from Vivani Medical, Inc.

[{"type":"text","content":" LOS ANGELES--(BUSINESS WIRE)--\nSecond Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its annual meeting held May 28, 2021.\n\nSecond Sight held its annual meeting online due to the COVID-19 pandemic. 60.98% of shareholders were present online or by proxy. Shareholders voted on four proposals: (1) electing six (6) members of the Board of Directors, to serve until the next annual meeting of shareholders in 2022 and until their successors are duly elected and qualified, (2) ratifying the appointment of Gumbiner Savett Inc. as our independent registered public accounting firm for 2021, (3) approving, on a non-binding advisory basis, the compensation of our named executive officers, and (4) indicating, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company’s named executive officers. The Board of Directors of the Company unanimously approved each of the Proposals and recommended that the shareholders approve each of the Proposals up for vote at the meeting. The results are:\n\nProposal 1: The shareholders elected each of the six director nominees to the Board of Directors of the Company to serve until the 2022 Annual Meeting of Shareholders or until their successors have been duly elected and qualified, as follows:\n\n\n\nNominee\n\n\n\n \n\n\n\nFor\n\n\n\n \n\n\n\nWithheld/ \n\n\nAbstentions\n\n\n\n \n\n\n\nBroker \n\n\nNon-Votes\n\n\n\n\n\nGregg Williams\n\n\n\n \n\n\n\n11,717,164\n\n\n\n \n\n\n\n125,819\n\n\n\n \n\n\n\n5,174,792\n\n\n\n\n\nAaron Mendelsohn\n\n\n\n \n\n\n\n11,710,856\n\n\n\n \n\n\n\n132,127\n\n\n\n \n\n\n\n5,174,792\n\n\n\n\n\nJonathan Will McGuire\n\n\n\n \n\n\n\n11,727,547\n\n\n\n \n\n\n\n115,436\n\n\n\n \n\n\n\n5,174,792\n\n\n\n\n\nMatthew Pfeffer\n\n\n\n \n\n\n\n11,728,271\n\n\n\n \n\n\n\n114,712\n\n\n\n \n\n\n\n5,174,792\n\n\n\n\n\nDean Baker\n\n\n\n \n\n\n\n11,734,708\n\n\n\n \n\n\n\n108,275\n\n\n\n \n\n\n\n5,174,792\n\n\n\n\n\nAlexandra Larson\n\n\n\n \n\n\n\n11,728,992\n\n\n\n \n\n\n\n113,991\n\n\n\n \n\n\n\n5,174,792\n\n\n\n\nProposal 2: The shareholders, on an advisory basis, ratified the appointment of Gumbiner Savett Inc. as Second Sight’s independen...

More updates from Vivani Medical, Inc.